Lam Research: Record Margins vs. China Exposure – Street Debate Heats Up

What happened

Lam Research continues to deliver strong financial performance, with record margins driven by AI-led wafer fab equipment demand, as highlighted in a bullish Seeking Alpha article. However, the latest SEC filings reveal a critical risk: 34% of revenue comes from China, and management explicitly warns that export license requirements 'are likely to be materially and adversely affected.' This creates a sharp divergence between the upbeat market narrative of a 'picks-and-shovels' AI winner and the reality of policy-driven downside. The DeepValue Master Report rates LRCX a WAIT, citing no margin of safety at 48x P/E and asymmetric risk from potential export curbs. Investors should question whether the current price already discounts this geopolitical overhang or if it will lead to multiple compression.

Implication

The bullish case hinges on sustaining >50% gross margins and rotating China mix lower, but the filings show no evidence of that happening. If the June 2026 quarter reveals any licensing friction or margin erosion, the 48x P/E multiple could contract sharply. Position sizing should reflect that the next 3-6 months will determine whether LRCX is a AI-infrastructure juggernaut or a policy hostage. Until then, the risk/reward is skewed to the downside.

Thesis delta

The DeepValue Master Report's WAIT rating contrasts with the article's Buy thesis by emphasizing policy risk over operating momentum. The report's base case of $255 implies ~2% downside from $259.5, while the article's $360-$380 implies 40% upside. The delta is that the filings' explicit 'materially and adversely affected' language on China sales is a stronger risk signal than the article acknowledges, making the bullish scenario contingent on a China mix shift that has not materialized.